Source / episode info

• **Episode:**102
• **Title:**Divine Intervention Episode 102 – The “Clutch” Cancer Podcast.
• **Published:**2019-05-19
• Source:Episode page

One-liner

This episode provides a comprehensive review of high-yield cancer associations across multiple organ systems, focusing on genetic predispositions (Lynch/APC), paraneoplastic syndromes (SCLC, Carcinoid), and classic diagnostic traps for GI and liver pathology.

High-yield summary

• Small Cell Lung Cancer (SCLC): Often produces ACTH (failure to suppress with high-dose dexamethasone) or ADH (SIADH -> euvolemic hyponatremia).
• Lambert-Eaton Myasthenic Syndrome (LEMS): Associated with SCLC; weakness improves with use and shows an incremental response on repetitive nerve stimulation.
• Carcinoid Syndrome: Caused by serotonin excess, leading to depletion of tryptophan -> Niacin deficiency -> Pellagra (Dermatitis, Diarrhea, Dementia).
• Barrett's Esophagus: The most common precursor for esophageal adenocarcinoma; the biggest risk factor is chronic GERD.
• HCC Risk Factors: Chronic HBV/HCV infection and cirrhosis are major risk factors for Hepatocellular Carcinoma.

Learning objectives

• Differentiate between the pathophysiology and clinical presentation of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
• Identify the key risk factors and screening guidelines for colorectal cancer (APC gene, Barrett's esophagus) and bladder cancer (Schistosoma).
• Recognize the paraneoplastic syndromes associated with SCLC (SIADH, ACTH) and other solid tumors (PTHrP, ADH).
• Understand the metabolic consequences of Carcinoid Syndrome due to tryptophan metabolism.
• Apply knowledge of liver pathology associations (HBV/HCV -> HCC; Colon cancer -> Liver metastasis).

Board exam buzzwords